Connect Biopharma Holdings (CNTB) Net Income (2024 - 2026)

Connect Biopharma Holdings has disclosed Net Income across 3 years of filings, most recently posting -$17.3 million for Q2 2026.

• In Q2 2026, Net Income fell 33.99% year-over-year to -$17.3 million; the TTM figure through Jun 2026 stood at -$69.0 million (down 53.47% YoY), while the FY2025 annual figure was -$55.5 million, down 255.0% from the prior year.
• Net Income came in at -$17.3 million for Q2 2026 at Connect Biopharma Holdings, up from -$19.4 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $14.8 million in Q2 2024 to a low of -$19.4 million in Q1 2026.
• Average Net Income over 3 years is -$10.8 million, with a median of -$12.9 million recorded in 2024.
• The largest YoY upside for Net Income was 18.16% in 2025 against a maximum downside of 186.88% in 2025.
• Over 3 years, Net Income stood at -$8.9 million in 2024, then sank by 69.65% to -$15.1 million in 2025, then fell by 14.4% to -$17.3 million in 2026.
• Per Business Quant data, the three most recent Net Income figures were -$17.3 million in Q2 2026, -$19.4 million in Q1 2026, and -$15.1 million in Q4 2025.